Fig. 7From: Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer’s disease modelsEffect of tolfenamic acid on the expression of p-tau and p-PP2A in hippocampus of ICV-OA mice. Tolfenamic acid treatment significantly decreased the expression of p-tau (Ser202 and Ser396) and p-PP2A (Y307), increased the expression of PP2A. All results are expressed as the mean ± SEM. n = 5; #p < 0.05, ##p < 0.01 versus control; *p < 0.05, **p < 0.01 versus modelBack to article page